CORC  > 山东大学
High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer
Jing, Wang; Wang, Shijiang; Ding, Xiao; Guo, Hongbo; Li, Ji; Wang, Haiyong; Kong, Li; Yu, Jinming; Zhu, Hui
刊名INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
2018
卷号11期号:5页码:2675-2682
关键词Small cell lung cancer PD-L1 immunohistochemistry overall survival prognostic factor
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4564957
专题山东大学
作者单位Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117
推荐引用方式
GB/T 7714
Jing, Wang,Wang, Shijiang,Ding, Xiao,et al. High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2018,11(5):2675-2682.
APA Jing, Wang.,Wang, Shijiang.,Ding, Xiao.,Guo, Hongbo.,Li, Ji.,...&Zhu, Hui.(2018).High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,11(5),2675-2682.
MLA Jing, Wang,et al."High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 11.5(2018):2675-2682.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace